I'm not sure there's a more intriguing small pharma out there. Too bad I only have 50 shares. If AUPH gets bought out before this one, that'll change.
>90% institutionally owned with only 36m shares outstanding.
Huge potential. Could easily see $50/share with the way LIVMARLI® is selling...